MoneyWorks4Me

Lasa Supergenerics - Quaterly Results

14 Aug 2024 Evaluate
The Total revenue for the quarter ended June 2024 of  Rs. 308.36 millions remain, more or less, the same.The Net Loss for the quarter ended June 2024 is Rs. -27.32 millions as compared to Net Loss of Rs. -49.49 millions of corresponding quarter ended June 2023A decline of 18.02 millions was observed in the OP in the quarter ended June 2024 from 40.54 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 308.36 305.56 0.92 308.36 305.56 0.92 1043.35 1295.68 -19.47
Other Income 0.05 0.04 25.00 0.05 0.04 25.00 0.99 18.05 -94.52
PBIDT 18.02 40.54 -55.55 18.02 40.54 -55.55 22.64 -47.89 -147.28
Interest 8.72 3.73 133.78 8.72 3.73 133.78 19.32 41.60 -53.56
PBDT 9.30 36.81 -74.74 9.30 36.81 -74.74 -84.41 -288.46 -70.74
Depreciation 27.94 26.50 5.43 27.94 26.50 5.43 106.73 134.19 -20.46
PBT -18.64 10.31 -280.80 -18.64 10.31 -280.80 -191.14 -422.65 -54.78
TAX 8.68 59.80 -85.48 8.68 59.80 -85.48 26.18 -36.45 -171.82
Deferred Tax 8.68 59.80 -85.48 8.68 59.80 -85.48 26.18 -36.88 -170.99
PAT -27.32 -49.49 -44.80 -27.32 -49.49 -44.80 -217.32 -386.20 -43.73
Equity 501.01 501.01 0.00 501.01 501.01 0.00 501.01 501.01 0.00
PBIDTM(%) 5.84 13.27 -55.95 5.84 13.27 -55.95 2.17 -3.70 -158.71
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..